319 related articles for article (PubMed ID: 1522358)
21. The occurrence of reactions and impairments in leprosy: experience in the leprosy control program of three provinces in northeastern Thailand, 1987-1995 [correction of 1978-1995]. I. Overview of the study.
Schreuder PA
Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):149-58. PubMed ID: 9728447
[TBL] [Abstract][Full Text] [Related]
22. Paucibacillary multidrug therapy in leprosy. 7 1/2 years experience.
Kaur S; Sharma VK; Basak P; Kaur I
Indian J Lepr; 1992; 64(2):153-61. PubMed ID: 1607713
[TBL] [Abstract][Full Text] [Related]
23. Preliminary appraisal of a WHO-recommended multiple drug regimen in paucibacillary leprosy patients in Malawi.
Boerrigter G; Ponnighaus JM; Fine PE
Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):408-17. PubMed ID: 3418206
[TBL] [Abstract][Full Text] [Related]
24. Problems of leprosy relapse in China.
Li HY
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):1-7. PubMed ID: 8326169
[TBL] [Abstract][Full Text] [Related]
25. The efficacy of a four-week, ofloxacin-containing regimen compared with standard WHO-MDT in PB leprosy.
Balagon MF; Cellona RV; Abalos RM; Gelber RH; Saunderson PR
Lepr Rev; 2010 Mar; 81(1):27-33. PubMed ID: 20496567
[TBL] [Abstract][Full Text] [Related]
26. Risk of relapse in leprosy after fixed-duration multidrug therapy.
Li HY; Hu LF; Huang WB; Liu GC; Yuan LC; Jin Z; Li X; Li JL; Yang ZM
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):238-45. PubMed ID: 9251597
[TBL] [Abstract][Full Text] [Related]
27. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
Mane I; Cartel JL; Grosset JH
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595
[TBL] [Abstract][Full Text] [Related]
28. Fixed-duration multidrug therapy in multibacillary leprosy.
Li HY; Hu LF; Wu PW; Luo JS; Liu XM
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):230-7. PubMed ID: 9251596
[TBL] [Abstract][Full Text] [Related]
29. A study on trend of relapse in leprosy and factors influencing relapse.
Ali MK; Thorat DM; Subramanian M; Parthasarathy G; Selvaraj U; Prabhakar V
Indian J Lepr; 2005; 77(2):105-15. PubMed ID: 16044808
[TBL] [Abstract][Full Text] [Related]
30. A comparative clinical trial in multibacillary leprosy with long-term relapse rates of four different multidrug regimens.
Fajardo TT; Villahermosa L; Pardillo FE; Abalos RM; Burgos J; Dela Cruz E; Gelber RH
Am J Trop Med Hyg; 2009 Aug; 81(2):330-4. PubMed ID: 19635893
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
[TBL] [Abstract][Full Text] [Related]
32. Deformity incidence in leprosy patients treated with multidrug therapy.
Rao PS; Subramanian M; Subramanian G
Indian J Lepr; 1994; 66(4):449-54. PubMed ID: 7714354
[TBL] [Abstract][Full Text] [Related]
33. Clinical analysis of multibacillary leprosy patients after 1-year fixed World Health Organization recommended multidrug therapy at Yangon General Hospital, Myanmar.
Kyaw K; Tsoh TM; Swe SY; Nagaoka Y; Takezaki S; Suzuki K; Ishii N
J Dermatol; 2008 May; 35(5):264-9. PubMed ID: 18477225
[TBL] [Abstract][Full Text] [Related]
34. Hansen's disease in Portugal: multibacillary patients treated between 1988 and 2003.
Medeiros S; Catorze MG; Vieira MR
J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):29-35. PubMed ID: 18713227
[TBL] [Abstract][Full Text] [Related]
35. Relapses in multibacillary leprosy patients after multidrug therapy.
Poojabylaiah M; Marne RB; Varikkodan R; Bala N; Dandakeri S; Martis J
Lepr Rev; 2008 Sep; 79(3):320-4. PubMed ID: 19009982
[TBL] [Abstract][Full Text] [Related]
36. Relapse after long-term follow up of multibacillary patients treated by WHO multidrug regimen. Marchoux Chemotherapy Study Group.
Jamet P; Ji B
Int J Lepr Other Mycobact Dis; 1995 Jun; 63(2):195-201. PubMed ID: 7602214
[TBL] [Abstract][Full Text] [Related]
37. Relapses in paucibacillary leprosy after MDT--a clinical study.
Grugni A; Nadkarni NJ; Kini MS; Mehta VR
Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):19-24. PubMed ID: 2319185
[TBL] [Abstract][Full Text] [Related]
38. Relapse of leprosy after multidrug therapy.
Dasananjali K
J Med Assoc Thai; 1996 Oct; 79(10):635-9. PubMed ID: 8996998
[TBL] [Abstract][Full Text] [Related]
39. Are defaulters with paucibacillary leprosy a problem?
Jesudasan K; Bradley D; Christian M
Indian J Lepr; 1985; 57(2):354-9. PubMed ID: 4078362
[TBL] [Abstract][Full Text] [Related]
40. Relapse rate in paucibacillary leprosy patients after multidrug therapy in North Arcot District.
Ekambaram V; Rao MK
Indian J Lepr; 1991; 63(1):34-42. PubMed ID: 1919088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
